Self-management of psoriasis vulgaris treatment burden: A Review

Medicine (Baltimore). 2023 Nov 3;102(44):e35392. doi: 10.1097/MD.0000000000035392.

Abstract

Psoriasis vulgaris is complicated with metabolic syndrome and other diseases, which affects the longevity of patients. Its repeated attacks bring obvious and long-term treatment burden to patients, and improper self-management can aggravate disease symptoms and increase the risk of complications. To summarize the existing evidence on the self-management of psoriasis vulgaris treatment burden. Systematic search was performed in database. Two researchers reviewed, extracted, and summarized evidence from the literature. Nine studies were included, of which 3 guidelines, the number of fields with standardized scores in various domains ≥60% of the evaluation results of the 3 guidelines was at least 4, quality evaluation are all above Grade B, demonstrated higher quality of guidelines, 3 RCTs, 2 analytical studies, and 2 literature reviews. The evaluation results of these included literatures were of high quality. We summarized the data in 6 areas, including oral medication management, topical treatment management, risk factors, living habits, physical exercise, and biologics managements. Finally, we present 34 items of best evidence. This study provides the basis for the management of treatment burden of psoriasis vulgaris. According to this study, medical workers guide patient to reduce the disease and treatment burden.

Publication types

  • Review

MeSH terms

  • Humans
  • Psoriasis* / therapy
  • Risk Factors
  • Self-Management*